Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

Genzyme

Information provided by (Responsible Party):

Roswell Park Cancer Institute

ClinicalTrials.gov Identifier:

NCT01003678

First received: October 27, 2009

Last updated: July 24, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	July 2013 (Final data collection date for primary outcome measure)